Legal mentions


Headquarters

ECHOSENS

30, Place d'Italie

75013 Paris - France

T. : 33+(1).44.82.78.50

F. : 33 +(1).44.82.78.60

Website : www.echosens.com

A French simplified joint stock company (Société par Actions Simplifiée) and share capital of 216.413 €

Siren number 438 209 157 RCS PARIS

Siret number 438 209 157 0066

APE code 8299Z

Intra-Community VAT number FR63 438 209 157

According to Articles 39 and following of French Law No. 78-17 dated January, 6th 1978 amended in 2004 relating to data, files and freedoms, any person may obtain and, if necessary, correct or delete information on addressing ECHOSENS - 30 Place d'Italie - 75013 PARIS.

Host providers

The compagny Xenpad hosts the institutionnal website.

http://www.xenpad.eu/

The compagny ATE hosts the Fibrovet tool website.

http://www.ate.info

[Echosens Library] - Revision date [08/18/2015] - FibroScan® is a medical device manufactured by Echosens. FibroScan is a CE marked Medical Device within the scope of the Medical Devices Directive. FibroScan® is indicated for the non-invasive measurement of liver stiffness (E) and controlled attenuation parameter (CAP) in humans. It is expressly recommended to carefully read the guidance within the users’ guide and the labeling of the device. FibroScan® examinations must only be performed at the request of qualified physician and by operators certified by the manufacturer or its accredited local representative. The values obtained with FibroScan® must be interpreted by a physician experienced in dealing with liver disease, taking into account the complete medical record of the patient. FibrometerTM i is classified as an in vitro diagnostic medical device and is manufactured by Echosens. FibrometerTM is a CE marked In Vitro Diagnostic Medical Device within the scope of the Medical Devices Directive. FibrometerTM scores are based on blood parameters and are indicated for the diagnosis and quantification of liver fibrosis in adult patients with chronic liver disease due to etiology. It is expressly recommended to carefully read the guidance within the users’ guide together with the labeling of the device. Examinations must be performed according to the pre analytical and analytical recommendations from the manufacturer (www.fibrometer.fr). The results are prepared by an analytical laboratory, following physician request. Results obtained must be interpreted by a physician experienced in dealing with liver disease, taking into account the complete medical record of the patient.

[May 2015]